Searched for
BIOGEN
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
- Not just Andaman: After fresh gas finds, India expands oil and gas hunt along east coastIndia is intensifying efforts to discover new oil and gas reserves along its eastern offshore frontier by reprocessing decades-old seismic ...
- Last date to buy these 12 stocks for dividends, bonus issues and more. Do you own any?Investors have until today to purchase shares in 12 companies, including SBI and IEX, to qualify for upcoming dividends, bonus issues, and ...
- Bonus issues, stock splits & dividends: SBI among 18 stocks turning ex-date this week. Do you own any?A total of 18 stocks will turn ex-date for corporate actions like dividends and bonus issues next week, with prominent names including Stat...
- Q4 earnings, crude oil, FII action among 8 factors to steer D-Street this weekIndian stock markets are set for a busy week. Key events like Q4 earnings announcements for many companies will influence trading. Foreign ...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian markets closed lower amid selling in financial, consumer and realty stocks, with Nifty and Sensex declining. Technical indicators si...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- US Stocks: Apellis shares double on Biogen's $5.6 billion buyout planBiogen will buy Apellis Pharmaceuticals for about $5.6 billion, adding a promising kidney disease drug to broaden its rare-disease portfoli...
- US Stocks: Biogen gets FDA approval for higher dose of genetic disorder drug, shares rise 3%The U.S. Food and Drug Administration has approved a higher dose of Biogen's spinal muscular atrophy drug Spinraza, the company said on M...
- Dr Reddy's Laboratories jumps into the fray for Biogen's biosimilarsDr Reddy's Laboratories (DRL) and Intas Pharmaceuticals, both Indian companies, are reportedly in the race to acquire the biosimilar produc...
- Roche's Alzheimer's drug fails to meet goal in long awaited trialRoche's Alzheimer's drug candidate could not be shown to markedly slow dementia progression in two drug trials, leaving rivals Biogen and E...
- Biogen appoints ex-Sinofi boss Christopher Viehbacher as its next CEO. Here are the detailsAfter a month gap in choosing the new CEO after Michel Vounatsos, Biogen has finally named Christopher Viehbacher as its new CEO.
- Biogen halves price of Alzheimer's drug to $28,200Biogen's $56,000 per year treatment price for an average weight person was seen as a significant cost burden on Medicare, which covers more...
- Nath Bio-Genes shares soar 11%. Here's whyAccording to the regulatory filing, the board will meet to consider the company's audited financial results in the meeting slated for Thurs...
- FDA approves much-debated Alzheimer's drug panned by expertsThe new drug, which Biogen developed with Japan's Eisai Co., did not reverse mental decline, only slowing it in one study. The drug is give...
- US FDA okays Biogen Alzheimer’s drugUS regulators on Monday approved Biogen’s aducanumab as the first treatment to address an underlying cause of Alzheimer’s disease despite c...
- Biogen Idec gets DCGI nod for multiple sclerosis oral drugThe company has received approval for the first oral therapy drug Tecfidera for multiple sclerosis by DCGI, Biogen Idec Biotech India Pvt L...
- Biogen to bring its global drug portfolio to IndiaUS-based Biogen Idec plans to roll out its entire range of medicines in the fast-growing, Rs 40,000-crore Indian retail drug market over th...
- Biogen for inlicensing deal with Indian cosUS-based biotech company Biogen Idec, is looking for partnerships across the pharma value chain, including in-licensing of new experimental...
Load More
